JP2007508381A5 - - Google Patents

Download PDF

Info

Publication number
JP2007508381A5
JP2007508381A5 JP2006535493A JP2006535493A JP2007508381A5 JP 2007508381 A5 JP2007508381 A5 JP 2007508381A5 JP 2006535493 A JP2006535493 A JP 2006535493A JP 2006535493 A JP2006535493 A JP 2006535493A JP 2007508381 A5 JP2007508381 A5 JP 2007508381A5
Authority
JP
Japan
Prior art keywords
formulation
sildenafil
aerosolized
delivery device
aerosol delivery
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2006535493A
Other languages
English (en)
Japanese (ja)
Other versions
JP2007508381A (ja
Filing date
Publication date
Priority claimed from US10/685,746 external-priority patent/US7258850B2/en
Application filed filed Critical
Publication of JP2007508381A publication Critical patent/JP2007508381A/ja
Publication of JP2007508381A5 publication Critical patent/JP2007508381A5/ja
Pending legal-status Critical Current

Links

JP2006535493A 2003-10-14 2004-09-09 勃起障害治療のための方法および組成物 Pending JP2007508381A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10/685,746 US7258850B2 (en) 1999-05-04 2003-10-14 Methods and compositions for treating erectile dysfunction
PCT/US2004/029374 WO2005039530A1 (en) 2003-10-14 2004-09-09 Methods and compositions for treating erectile dysfunction

Publications (2)

Publication Number Publication Date
JP2007508381A JP2007508381A (ja) 2007-04-05
JP2007508381A5 true JP2007508381A5 (https=) 2007-09-20

Family

ID=34520662

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2006535493A Pending JP2007508381A (ja) 2003-10-14 2004-09-09 勃起障害治療のための方法および組成物

Country Status (5)

Country Link
US (3) US7258850B2 (https=)
EP (1) EP1677754A4 (https=)
JP (1) JP2007508381A (https=)
CA (1) CA2539845A1 (https=)
WO (1) WO2005039530A1 (https=)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7258850B2 (en) * 1999-05-04 2007-08-21 Aradigm Corporation Methods and compositions for treating erectile dysfunction
US7235625B2 (en) 1999-06-29 2007-06-26 Palatin Technologies, Inc. Multiple agent therapy for sexual dysfunction
US20030229001A1 (en) * 2002-01-31 2003-12-11 Pfizer Inc. Treatment of male sexual dysfunction
AU2003903597A0 (en) * 2003-07-11 2003-07-24 Jakov Vaisman Treatment of premature ejaculation
SI1750766T1 (sl) 2004-05-11 2013-11-29 Emotional Brain B.V. Farmacevtske formulacije in njihove uporabe pri zdravljenju spolne disfunkcije pri Ĺľenskah
CN101014321A (zh) * 2004-08-23 2007-08-08 曼金德公司 5型磷酸二酯酶抑制剂的肺部给予
EP1790343A1 (en) 2005-11-11 2007-05-30 Emotional Brain B.V. Pharmaceuticals formulations and uses thereof in the treatment of female sexual dysfunction
EP1925307A1 (en) 2006-11-03 2008-05-28 Emotional Brain B.V. Use of 3-alpha-androstanediol in the treatment of sexual dysfunction
US20090181975A1 (en) * 2008-01-15 2009-07-16 Forest Laboratories Holdings Limited Nebivolol in the treatment of sexual dysfunction
EP2285362B1 (en) * 2008-06-19 2017-08-09 LTS LOHMANN Therapie-Systeme AG Composition for transdermal delivery of cationic active agents
CA2802047C (en) * 2010-06-07 2019-05-07 Novadel Pharma Inc. Oral spray formulations and methods for administration of sildenafil
WO2015195711A2 (en) * 2014-06-16 2015-12-23 Shurtleff, James, Kevin Method and devices for manufacturing and delivering of aerosolized formulations
US11977085B1 (en) 2023-09-05 2024-05-07 Elan Ehrlich Date rape drug detection device and method of using same

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3686025T2 (de) * 1985-05-22 1993-01-07 Liposome Technology Inc Verfahren und system zum einatmen von liposomen.
GB9114760D0 (en) * 1991-07-09 1991-08-28 Pfizer Ltd Therapeutic agents
EP0725074A3 (en) * 1992-04-20 1996-11-20 Sankyo Co Intermediate compounds for the preparation of androst-3,5-diene-3-carboxy derivatives
US5756071A (en) * 1992-06-03 1998-05-26 Arrowdean Limited Method for nasally administering aerosols of therapeutic agents to enhance penetration of the blood brain barrier
JPH06211675A (ja) 1993-01-11 1994-08-02 Shiro Tezuka 山椒入り局部塗付液
US5497763A (en) * 1993-05-21 1996-03-12 Aradigm Corporation Disposable package for intrapulmonary delivery of aerosolized formulations
GB9311920D0 (en) * 1993-06-09 1993-07-28 Pfizer Ltd Therapeutic agents
US6395744B1 (en) * 1994-04-22 2002-05-28 Queen's University At Kingston Method and compositions for the treatment or amelioration of female sexual dysfunction
JP3310982B2 (ja) * 1994-04-22 2002-08-05 ペンテツク・フアーマシユーテイカルズ・インコーポレイテツド 男性の勃起機能不全を改善するための剤形及び方法
AUPN814496A0 (en) 1996-02-19 1996-03-14 Monash University Dermal penetration enhancer
US6077543A (en) 1996-12-31 2000-06-20 Inhale Therapeutic Systems Systems and processes for spray drying hydrophobic drugs with hydrophilic excipients
DE69732306T2 (de) 1997-01-16 2006-01-12 Massachusetts Institute Of Technology, Cambridge Zubereitung von partikelhaltigen arzneimitteln zur inhalation
AU718967B2 (en) 1997-02-05 2000-05-04 Jagotec Ag Medical aerosol formulations
US6037346A (en) * 1997-10-28 2000-03-14 Vivus, Inc. Local administration of phosphodiesterase inhibitors for the treatment of erectile dysfunction
US5877216A (en) * 1997-10-28 1999-03-02 Vivus, Incorporated Treatment of female sexual dysfunction
WO1999027905A1 (en) * 1997-12-02 1999-06-10 West Pharmaceutical Services Drug Delivery & Clinical Research Centre Limited Compositions for nasal administration
JP4570251B2 (ja) * 1998-07-24 2010-10-27 ヤゴテック アーゲー 医薬用エーロゾル製剤
AU756852B2 (en) * 1998-11-13 2003-01-23 Jagotec Ag Dry powder for inhalation
US6455564B1 (en) 1999-01-06 2002-09-24 Pharmacia & Upjohn Company Method of treating sexual disturbances
US20010053780A1 (en) * 1999-04-30 2001-12-20 Whitaker John S. Daily treatment for erectile dysfunction using a PDE5 inhibitor
US7258850B2 (en) * 1999-05-04 2007-08-21 Aradigm Corporation Methods and compositions for treating erectile dysfunction
US6632419B2 (en) * 1999-05-04 2003-10-14 Aradigm Corporation Increasing libido in humans via acute testosterone administration
US6428769B1 (en) * 1999-05-04 2002-08-06 Aradigm Corporation Acute testosterone administration
US6579968B1 (en) * 1999-06-29 2003-06-17 Palatin Technologies, Inc. Compositions and methods for treatment of sexual dysfunction
TW200400821A (en) 1999-11-02 2004-01-16 Pfizer Pharmaceutical composition (II) useful for treating or preventing pulmonary hypertension in a patient
GB0021487D0 (en) * 2000-09-01 2000-10-18 Pfizer Ltd Pharmaceutical
US20030119714A1 (en) * 2000-12-15 2003-06-26 Naylor Alasdair Mark Treatment of male sexual dysfunction
CA2446904A1 (en) * 2001-05-24 2003-04-03 Alexza Pharmaceuticals, Inc. Delivery of drug esters through an inhalation route
CN1700934B (zh) * 2002-09-06 2011-08-03 菲利普莫里斯美国公司 液体气溶胶制剂和用于制备气溶胶的气溶胶产生装置及方法
US20040204439A1 (en) * 2003-04-14 2004-10-14 Staniforth John Nicholas Composition, device, and method for treating sexual dysfunction via inhalation

Similar Documents

Publication Publication Date Title
JP2007508381A5 (https=)
JP2007500210A5 (https=)
EP4393478A3 (en) Compositions, methods and systems for aerosol drug delivery
WO2001073431A3 (en) Biomedical assay device
JP2004536805A5 (https=)
RU2008130763A (ru) Сублингвальный аэрозоль на основе фентанила
JP4190732B2 (ja) 抗真菌活性化合物を含む経口医薬組成物およびその製法
WO2009151572A3 (en) Compositions containing a solvated active agent suitable for dispensing as a compressed gas aerosol
WO2007106386A3 (en) Nozzle pore configuration for intrapulmonary delivery of aerosolized formulations
JP2008521788A5 (https=)
CA2561109A1 (en) Gastric retention system
WO2006017341A3 (en) Coated vaginal devices for vaginal delivery of therapeutically effective and/ or health-promoting agents
JP2005523119A5 (https=)
NZ602968A (en) Extended release formulation containing a wax
IS2856B (is) Lyfjablanda úr ómeprasól
RU2015104649A (ru) Системы и способы доставки сухих порошковых лекарств
PT2350047E (pt) Inibidor de p38 mapk quinase
RS51313B (sr) Retard tablete sa hidromorfonom
WO2000040205A3 (en) Sustained release formulation with reduced moisture sensitivity
JP2009519350A5 (https=)
WO2008013833A3 (en) Orally dissolvable/disintegrable lyophilized dosage forms containing protected particles
IT1317720B1 (it) Dispositivo per la somministrazione di aerosol dosati pressurizzati inpropellenti idrofluoroalcani.
RU2008130171A (ru) Маскирование вкуса порошков
JP2018505187A5 (https=)
JP2005503383A5 (https=)